| Therapeutic myocardial angiogenesis. | |
| | |
MedLine Citation:
|
PMID: 17950369 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Armed with an improved understanding of the mediators of angiogenesis, physicians and scientists have made significant efforts at harnessing this naturally occurring process in order to treat patients with a variety of peripheral vascular and coronary ischemic syndromes. There is a growing population of patients with end-stage coronary artery disease (CAD) who are no longer candidates for mechanical revascularization, yet suffer from chronic myocardial ischemia who may benefit from regeneration of the depleted microvasculature. |
| | |
Authors:
|
Marie-Ange Renault; Douglas W Losordo |
Related Documents
:
|
8465739 - Identification of high-risk patients with left main and three-vessel coronary artery di... 17653519 - Increased prevalence of ventricular fibrillation in patients with type 2 diabetes melli... 19615769 - Left atrial volume and index by multi-detector computed tomography: comprehensive analy... 9605599 - Benefits of combination therapy in hypertensive patients with associated coronary arter... 2662729 - Antianginal and cardiac metabolic effects of low-dose glucose infusion during pacing in... 20827179 - Evolving focus on diastolic dysfunction in patients with coronary artery disease. 9708469 - Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transpl... 14566249 - Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged me... 10509239 - Predictive value of regional left ventricular circumferential shortening in jeopardized... |
Publication Detail:
|
Type: Journal Article; Review Date: 2007-09-07 |
Journal Detail:
|
Title: Microvascular research Volume: 74 ISSN: 0026-2862 ISO Abbreviation: Microvasc. Res. Publication Date: 2007 Sep-Nov |
Date Detail:
|
Created Date: 2007-11-12 Completed Date: 2008-01-08 Revised Date: 2011-09-26 |
Medline Journal Info:
|
Nlm Unique ID: 0165035 Medline TA: Microvasc Res Country: United States |
Other Details:
|
Languages: eng Pagination: 159-71 Citation Subset: IM |
Affiliation:
|
Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave., Tarry 12-703, Chicago, IL 60611, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiogenesis Inducing Agents
/
pharmacology*,
therapeutic use* Animals Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Forecasting Gene Therapy / methods Gene Transfer Techniques Humans Myocardial Ischemia / drug therapy* Myocardial Revascularization / methods* Neovascularization, Physiologic / physiology Tissue Therapy / methods |
| Grant Support | |
ID/Acronym/Agency:
|
R01 HL057516-05/HL/NHLBI NIH HHS; R01 HL057516-06/HL/NHLBI NIH HHS; R01 HL057516-07/HL/NHLBI NIH HHS; R01 HL057516-08/HL/NHLBI NIH HHS; R01 HL057516-09/HL/NHLBI NIH HHS; R01 HL057516-10/HL/NHLBI NIH HHS; R01 HL057516-11/HL/NHLBI NIH HHS; R01 HL063414-01/HL/NHLBI NIH HHS; R01 HL063414-02/HL/NHLBI NIH HHS; R01 HL063414-03/HL/NHLBI NIH HHS; R01 HL063414-04/HL/NHLBI NIH HHS; R01 HL063414-05A1/HL/NHLBI NIH HHS; R01 HL063414-06/HL/NHLBI NIH HHS; R01 HL063414-07/HL/NHLBI NIH HHS; R01 HL063414-08/HL/NHLBI NIH HHS; R01 HL077428-01A2/HL/NHLBI NIH HHS; R01 HL077428-02/HL/NHLBI NIH HHS; R01 HL080137-01A1/HL/NHLBI NIH HHS; R01 HL080137-02/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Angiogenesis Inducing Agents |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Potential therapeutic strategies for lymphatic metastasis.
Next Document: Similarities between angiogenesis and neural development: what small animal models can tell us.